Full title: Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen (CHONQUER)
Age: 18+
Locations:
- London – The Royal Marsden
- Manchester – Christie Hospital, Royal Manchester Children’s Hospital
Brief summary:
Chonquer is a phase III is an international clinical trial examining a ivosidenib as a treatment option for people with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
